A detailed history of Darwin Advisors, LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Darwin Advisors, LLC holds 348 shares of WST stock, worth $109,442. This represents 0.03% of its overall portfolio holdings.

Number of Shares
348
Holding current value
$109,442
% of portfolio
0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$277.16 - $333.3 $96,451 - $115,988
348 New
348 $104,000
Q4 2020

Feb 16, 2021

SELL
$261.16 - $301.66 $2.83 Million - $3.27 Million
-10,830 Closed
0 $0
Q3 2020

Oct 16, 2020

BUY
$224.99 - $288.02 $2.44 Million - $3.12 Million
10,830 New
10,830 $2.98 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $23.3B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Darwin Advisors, LLC Portfolio

Follow Darwin Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Darwin Advisors, LLC with notifications on news.